[Epidemiology and manifestations of Sjögren's disease].

Martin Aringer, Anne-Kathrin Tausche

Abstract readEnglish Abstract

In one paragraph

Article in Zeitschrift fur Rheumatologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Martin AringerRheumatologie, Medizinische Klinik und Poliklinik III, und UniversitätsCentrum für Autoimmun- und Rheumatische Erkrankungen (UCARE), Universitätsklinikum und Medizinische Fakultät, TU Dresden, Fetscherstr. 74, 01307, Dresden, Deutschland. martin.aringer@uniklinikum-dresden.de.ORCID http://orcid.org/0000-0003-4471-8375

Anne-Kathrin TauscheRheumatologie, Medizinische Klinik und Poliklinik III, und UniversitätsCentrum für Autoimmun- und Rheumatische Erkrankungen (UCARE), Universitätsklinikum und Medizinische Fakultät, TU Dresden, Fetscherstr. 74, 01307, Dresden, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While the name of Sjögren's syndrome was recently changed to Sjögren's disease (SjD), the picture of a systemic autoimmune disease with inflammation of the exocrine glands and subsequent dryness has remained unchanged since the first description. This includes a pronounced B‑cell activity with an increased risk of lymphoma, frequent fatigue and arthralgia and relevant organ involvement in some patients. The prevalence in Germany is estimated to be around 7:10,000, slightly higher than for systemic lupus erythematosus (SLE). Women are affected roughly ten times more often than men. The classification criteria are based on antibodies against Ro/SS‑A antigens or a salivary gland biopsy, supplemented by the objective proof of dryness. In view of the now well-established and typical sonographic findings, they could be supplemented by sonographic parameters.

Indexed as

ArthralgiaFatigueLymphomaSjogren's SyndromeAge DistributionCausalityComorbidityFemaleGermanyHumansIncidenceMalePrevalenceRisk FactorsSex DistributionDry eye syndromeEpidemiologyInternal organ manifestationsLymphomaSalivary gland involvement

Identifiers

PMID41790166

DOI10.1007/s00393-026-01796-3

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.